1. Prevalence and prognostic implications of reduced left ventricular ejection fraction among patients with STEMI in India
- Author
-
Hendrickson, Michael J, Arora, Sameer, Vaduganathan, Muthiah, Fonarow, Gregg C, Mp, Girish, Bansal, Ankit, Batra, Vishal, Kunal, Shekhar, Bhatt, Deepak L, Gupta, Mohit, and Qamar, Arman
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Patient Safety ,Clinical Research ,Prevention ,Good Health and Well Being ,Humans ,ST Elevation Myocardial Infarction ,Prognosis ,Ventricular Function ,Left ,Stroke Volume ,Prevalence ,Angiotensin Receptor Antagonists ,Angiotensin-Converting Enzyme Inhibitors ,NORIN-STEMI ,ST-elevation myocardial infarction ,atherosclerotic cardiovascular disease ,heart failure ,left ventricular dysfunction ,Cardiorespiratory Medicine and Haematology ,Cardiovascular medicine and haematology - Abstract
AimsTo describe clinical characteristics and outcomes for those with STEMI and reduced left ventricular ejection fraction (LVEF) in low-income and middle-income countries (LMICs).Methods and resultsAdults presenting with STEMI to two government-owned tertiary care centres in Delhi, India were prospectively enrolled in the North India ST-elevation myocardial infarction (NORIN-STEMI) registry. LVEF was evaluated at presentation and clinical characteristics were compared across LVEF categories. Overall, 3597 patients were included, of whom 468 (13%) had LVEF >50%, 1482 (41%) had mildly reduced LVEF (40-49%), 1357 (38%) had moderately reduced LVEF (30-39%), and 290 (8%) had severely reduced LVEF (24 h, prior MI, and hyperlipidaemia were associated with decreasing LVEF category. Although most patients with reduced LVEF were discharged on appropriate guideline-directed therapies, adherence at 1 year was low (ACE inhibitor/ARB 91% to 41%, beta blocker 98% to 78%, aldosterone receptor antagonist 69% to 6%). After multivariable adjustment, a Cox regression model showed moderately reduced LVEF (HR 1.77, 95% CI 1.20, 2.60) and severely reduced LVEF (HR 3.63, 95% CI 2.41, 5.48) were associated with increased risk of all-cause mortality compared with LVEF ≥50%.ConclusionsOn presentation for STEMI, almost 90% of NORIN-STEMI participants had at least mildly reduced LVEF and almost half had LVEF
- Published
- 2022